US Broker Ratings

Tarsus Pharmaceuticals (TARS) Stock Analysis: A Biotech Gem with 42% Potential Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a burgeoning name in the biotechnology sector, has captured the attention of investors with its promising therapeutic candidates in the field..

Sotera Health Company (SHC) Stock Analysis: A Solid 22.95% Potential Upside in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC) is capturing the attention of investors with its compelling 22.95% potential upside, according to recent analyst ratings. As a key player..

Schrodinger, Inc. (SDGR) Stock Analysis: Navigating Growth Amidst Challenging Metrics

Schrodinger, Inc. (NASDAQ: SDGR), a company at the intersection of healthcare and technology, is gaining attention for its pioneering work in computational platforms that drive drug..

Privia Health Group, Inc. (PRVA) Stock Analysis: Uncovering a 42% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA), a key player in the healthcare sector, is gaining attention for its robust growth prospects and compelling valuation metrics. As..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Revenue Growth and Analyst Optimism Signal a Promising 34% Upside

Kiniksa Pharmaceuticals International (NASDAQ: KNSA), a notable player in the biopharmaceutical sector, is making waves with its promising therapeutic developments. With a market capitalization of $5.61..

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis: Exploring an 82.63% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a biotechnology company based in Pasadena, California, is turning heads in the investment world with its cutting-edge RNA interference (RNAi) technology..

QuidelOrtho Corporation (QDEL) Stock Analysis: Understanding the 6.51% Upside Potential

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector and the medical devices industry, presents a compelling case for investors seeking exposure to the..

Immunocore Holdings plc (IMCR) Stock Analysis: A Biotech Powerhouse with 100% Upside Potential

Immunocore Holdings plc (NASDAQ: IMCR) stands out in the biotechnology sector with an impressive potential upside of 100.53%, according to analyst ratings. Headquartered in Abingdon, United..

Enovis Corporation (ENOV) Stock Analysis: A Promising 70% Upside in the Healthcare Sector

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with a potential upside of 70.53%...

PGIM Securitized Income ETF (PINC) Stock Analysis: Navigating Stability with a $4.08 Billion Market Cap

For individual investors seeking exposure to securitized credit investments, the PGIM Securitized Income ETF (PINC) stands out as a notable option. With a market capitalization of..

Mesoblast Limited (MESO) Stock Analysis: Exploring a Promising 198.63% Upside in the Biotechnology Sector

Mesoblast Limited (NASDAQ: MESO), a pioneering name in the biotechnology sector, has positioned itself as a formidable player in the realm of regenerative medicine. With a..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Understanding the Challenges and Opportunities in Biotech

Apogee Therapeutics, Inc. (NASDAQ: APGE), a prominent player in the biotechnology sector, presents a compelling case for investors interested in the healthcare space. Based in San..

Clover Health Investments (CLOV) Stock Analysis: Navigating a 17.87% Potential Upside in Healthcare Plans

Clover Health Investments, Corp (CLOV) is carving out a niche in the healthcare sector, primarily focusing on Medicare Advantage plans. With a market cap of $2.42..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Exploring a Potential 95% Upside Amidst Challenges

Brookdale Senior Living Inc. (BKD) stands at a pivotal moment for investors seeking opportunities in the healthcare sector, particularly within the medical care facilities industry. With..

Liquidia Corporation (LQDA): An Investor’s Guide to a Biopharma Powerhouse with 24% Upside Potential

Liquidia Corporation (NASDAQ: LQDA), a prominent player in the healthcare sector, is making waves in the biopharmaceutical landscape with its innovative approach to treating rare cardiopulmonary..

Twist Bioscience Corporation (TWST) Stock Analysis: Is the Biotech Innovator Poised for Growth?

Twist Bioscience Corporation (NASDAQ: TWST) is capturing investor attention in the biotechnology sector with its innovative approach to synthetic DNA manufacturing. As a key player headquartered..

Disc Medicine, Inc. (IRON) Stock Analysis: A 61.92% Upside Potential in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON) is capturing investor interest with a potential upside of 61.92%, driven by its innovative approach in the biotechnology sector. Headquartered in..

Ascentage Pharma Group Internat (AAPG): A Promising Biotech with 188% Potential Upside

Ascentage Pharma Group International (AAPG), a key player in the biotechnology sector, is capturing the attention of investors with its impressive growth potential and strategic focus..

Surgery Partners, Inc. (SGRY) Stock Analysis: Evaluating Market Performance Amid Healthcare Growth

Surgery Partners, Inc. (NASDAQ: SGRY), a prominent player in the healthcare sector, operates a network of surgical facilities across the United States. Known for its focus..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a Potential 141% Upside for Investors

MoonLake Immunotherapeutics (NASDAQ: MLTX), a promising player in the biotechnology sector, has captured the attention of investors with its ambitious approach to tackling inflammatory skin and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds